vs
Side-by-side financial comparison of First Foundation Inc. (FFWM) and STEM, INC. (STEM). Click either name above to swap in a different company.
First Foundation Inc. is the larger business by last-quarter revenue ($48.4M vs $47.1M, roughly 1.0× STEM, INC.). STEM, INC. runs the higher net margin — -33.9% vs -97.9%, a 64.0% gap on every dollar of revenue. On growth, First Foundation Inc. posted the faster year-over-year revenue change (421.7% vs -15.6%). Over the past eight quarters, STEM, INC.'s revenue compounded faster (36.1% CAGR vs -2.7%).
John B. Lacson Colleges Foundation (Bacolod), Inc. is a private maritime college in Bacolod, Negros Occidental, Philippines.
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
FFWM vs STEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $48.4M | $47.1M |
| Net Profit | $-8.0M | $-16.0M |
| Gross Margin | — | 48.9% |
| Operating Margin | -97.5% | -17.7% |
| Net Margin | -97.9% | -33.9% |
| Revenue YoY | 421.7% | -15.6% |
| Net Profit YoY | 43.0% | 68.8% |
| EPS (diluted) | $-0.09 | $-4.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $48.4M | $47.1M | ||
| Q3 25 | $63.6M | $38.2M | ||
| Q2 25 | $51.4M | $38.4M | ||
| Q1 25 | $71.4M | $32.5M | ||
| Q4 24 | $9.3M | $55.8M | ||
| Q3 24 | $9.2M | $29.3M | ||
| Q2 24 | $57.5M | $34.0M | ||
| Q1 24 | $51.1M | $25.5M |
| Q4 25 | $-8.0M | $-16.0M | ||
| Q3 25 | $-146.3M | $-23.8M | ||
| Q2 25 | $-7.7M | $202.5M | ||
| Q1 25 | $6.9M | $-25.0M | ||
| Q4 24 | $-14.1M | $-51.1M | ||
| Q3 24 | $-82.2M | $-148.3M | ||
| Q2 24 | $3.1M | $-582.3M | ||
| Q1 24 | $793.0K | $-72.3M |
| Q4 25 | — | 48.9% | ||
| Q3 25 | — | 35.5% | ||
| Q2 25 | — | 33.4% | ||
| Q1 25 | — | 32.4% | ||
| Q4 24 | — | -4.4% | ||
| Q3 24 | — | 21.2% | ||
| Q2 24 | — | 27.6% | ||
| Q1 24 | — | -95.0% |
| Q4 25 | -97.5% | -17.7% | ||
| Q3 25 | -92.7% | -33.6% | ||
| Q2 25 | -21.1% | -34.8% | ||
| Q1 25 | 8.8% | -65.0% | ||
| Q4 24 | -247.7% | -84.4% | ||
| Q3 24 | -1276.7% | -493.2% | ||
| Q2 24 | 4.6% | -1705.5% | ||
| Q1 24 | -0.2% | -267.0% |
| Q4 25 | -97.9% | -33.9% | ||
| Q3 25 | -230.1% | -62.2% | ||
| Q2 25 | -15.0% | 527.8% | ||
| Q1 25 | 9.7% | -76.9% | ||
| Q4 24 | -152.2% | -91.6% | ||
| Q3 24 | -896.9% | -506.3% | ||
| Q2 24 | 5.4% | -1712.6% | ||
| Q1 24 | 1.6% | -283.9% |
| Q4 25 | $-0.09 | $-4.40 | ||
| Q3 25 | $-1.78 | $-2.84 | ||
| Q2 25 | $-0.09 | $-1.79 | ||
| Q1 25 | $0.08 | $-0.15 | ||
| Q4 24 | $-0.24 | $-15.29 | ||
| Q3 24 | $-1.23 | $-18.24 | ||
| Q2 24 | $0.05 | $-71.81 | ||
| Q1 24 | $0.01 | $-0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.6B | $48.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $912.6M | $-249.4M |
| Total Assets | $11.9B | $308.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.6B | $48.9M | ||
| Q3 25 | $1.7B | $43.1M | ||
| Q2 25 | $1.1B | $40.8M | ||
| Q1 25 | $1.0B | $58.6M | ||
| Q4 24 | $1.0B | $56.3M | ||
| Q3 24 | $1.1B | $75.4M | ||
| Q2 24 | $1.4B | $89.6M | ||
| Q1 24 | $1.6B | $112.8M |
| Q4 25 | $912.6M | $-249.4M | ||
| Q3 25 | $917.9M | $-235.7M | ||
| Q2 25 | $1.1B | $-214.1M | ||
| Q1 25 | $1.1B | $-417.5M | ||
| Q4 24 | $1.1B | $-398.4M | ||
| Q3 24 | $1.1B | $-344.1M | ||
| Q2 24 | $933.2M | $-203.2M | ||
| Q1 24 | $928.7M | $371.6M |
| Q4 25 | $11.9B | $308.9M | ||
| Q3 25 | $11.9B | $362.6M | ||
| Q2 25 | $11.6B | $379.2M | ||
| Q1 25 | $12.6B | $405.1M | ||
| Q4 24 | $12.6B | $437.4M | ||
| Q3 24 | $13.4B | $537.8M | ||
| Q2 24 | $13.7B | $691.5M | ||
| Q1 24 | $13.6B | $1.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-31.9M | $8.2M |
| Free Cash FlowOCF − Capex | $-35.2M | — |
| FCF MarginFCF / Revenue | -72.8% | — |
| Capex IntensityCapex / Revenue | 6.9% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-45.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-31.9M | $8.2M | ||
| Q3 25 | $9.2M | $11.4M | ||
| Q2 25 | $-16.3M | $-21.3M | ||
| Q1 25 | $-552.0K | $8.5M | ||
| Q4 24 | $-8.7M | $-14.7M | ||
| Q3 24 | $14.2M | $-9.4M | ||
| Q2 24 | $-9.1M | $-11.9M | ||
| Q1 24 | $7.2M | $-621.0K |
| Q4 25 | $-35.2M | — | ||
| Q3 25 | $8.6M | — | ||
| Q2 25 | $-16.7M | — | ||
| Q1 25 | $-2.5M | — | ||
| Q4 24 | $-11.4M | — | ||
| Q3 24 | $13.4M | — | ||
| Q2 24 | $-9.4M | — | ||
| Q1 24 | $5.9M | — |
| Q4 25 | -72.8% | — | ||
| Q3 25 | 13.5% | — | ||
| Q2 25 | -32.4% | — | ||
| Q1 25 | -3.5% | — | ||
| Q4 24 | -123.5% | — | ||
| Q3 24 | 146.2% | — | ||
| Q2 24 | -16.3% | — | ||
| Q1 24 | 11.6% | — |
| Q4 25 | 6.9% | — | ||
| Q3 25 | 1.0% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 2.8% | — | ||
| Q4 24 | 29.4% | — | ||
| Q3 24 | 9.0% | — | ||
| Q2 24 | 0.4% | — | ||
| Q1 24 | 2.5% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.11× | ||
| Q1 25 | -0.08× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -2.96× | — | ||
| Q1 24 | 9.09× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
